Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial

被引:0
|
作者
Shi-Bing Liang
Mei Han
Hong-Jie Cheng
Qiao-Yan Zhang
Nai-Wei Zhang
Bo-Yi Jia
Nicola Robinson
Jian-Ping Liu
机构
[1] Beijing University of Chinese Medicine,Centre for Evidence
[2] Beijing University of Chinese Medicine,Based Chinese Medicine
[3] Fangshan Hospital of Beijing University of Chinese Medicine,Institute for Excellence in Evidence
[4] Institute for Health and Social Care,Based Chinese Medicine
[5] London South Bank University,undefined
来源
Trials | / 23卷
关键词
Tongxie Yaofang; Chinese herbal medicine; Irritable bowel syndrome; IBS-D; Randomized controlled trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial
    Liang, Shi-Bing
    Han, Mei
    Cheng, Hong-Jie
    Zhang, Qiao-Yan
    Zhang, Nai-Wei
    Jia, Bo-Yi
    Robinson, Nicola
    Liu, Jian-Ping
    [J]. TRIALS, 2022, 23 (01)
  • [2] Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: A randomized placebo-controlled trial
    Leung, Wai K.
    Wu, Justin C. Y.
    Liang, S. M.
    Chan, L. S.
    Chan, Francis K. L.
    Xie, He
    Fung, Sara S. L.
    Hui, Aric J.
    Wong, Vincent W. S.
    Che, Chun-Tao
    Sung, Joseph J. Y.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (07): : 1574 - 1580
  • [3] Tong-xie-ning, a Chinese herbal formula, in treatment of diarrhea-predominant irritable bowel syndrome: a prospective, randomized, double-blind, placebo-controlled trial
    Wang Gang
    Li Ting-qian
    Wang Lei
    Xia Qing
    Chang Jing
    Zhang Ying
    Wan Mei-hua
    Guo Jia
    Cheng Yan
    Huang Xi
    Zhang Rui-ming
    [J]. CHINESE MEDICAL JOURNAL, 2006, 119 (24) : 2114 - 2119
  • [5] Tong-xie-ning,a Chinese herbal formula,in treatment of diarrhea-predominant irritable bowel syndrome:a prospective,randomized,double-blind,placebo-controlled trial
    WANG GangLI TingqianWANG LeiXIA QingCHANG JingZHANG YingWAN MeihuaGUO JiaCHENG YanHUANG Xi and ZHANG Ruiming Department of Integrated Traditional Chinese and Western MedicineWest China HospitalSichuan UniversityChengdu China
    [J]. ChineseMedicalJournal, 2006, (24) : 2114 - 2119
  • [6] The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial
    Guo, Xiaohui
    Xuan, Meiling
    Zheng, Huan
    Qin, Shumin
    Wu, Haomeng
    Huang, Shaogang
    Wen, Zehuai
    [J]. TRIALS, 2021, 22 (01)
  • [7] The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial
    Xiaohui Guo
    Meiling Xuan
    Huan Zheng
    Shumin Qin
    Haomeng Wu
    Shaogang Huang
    Zehuai Wen
    [J]. Trials, 22
  • [8] Modified Gwakjeongtang for Diarrhea-Predominant Irritable Bowel Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Trial
    Choi, Yujin
    Ha, Na-Yeon
    Kim, Ae-Ran
    Jeong, Haein
    Kwon, Ojin
    Park, Ki-Sun
    Kim, Jieun
    Kim, Jinsung
    Kim, Hyungjun
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 1545 - 1556
  • [9] Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials
    Liang, Shi-Bing
    Cao, Hui-Juan
    Kong, Ling-Yao
    Wei, Jia-Li
    Robinson, Nicola
    Yang, Si-Hong
    Zhu, Si-Jia
    Li, Yu-Qi
    Fei, Yu-Tong
    Han, Mei
    Liu, Jian-Ping
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Overview of systematic evaluation of efficacy of Tongxie Yaofang in treating diarrhea-predominant irritable bowel syndrome
    Chen, Xuan
    Yu, Xiaowen
    Shi, Yaxiang
    Shen, Hong
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (08) : 9223 - 9232